61 / 112
59
WFSBP 2015
Wednesday, 17 June 2015
|
Scientific Programme
S-34-002
Disruption of thalamocortical activity in psychedelic models
in animals
Francesc Artigas, Spain
S-34-003
EEG power spectra and connectivity changes as biomarkers
of psychedelic effects in animal models
Tomas Palenicek, Czech Republic
S-34-004
Neuroimaging and behavioral studies of cognitive and
emotional effects of serotonergic hallucinogens in humans
Franz Vollenweider, Switzerland
R. Krähenmann, E. Seifritz, K. Preller
T44: S
timulation
M
ethods
(ECT, TMS, VNS, DBS)
S-35
Symposium
08:30–10:00
MC 2 Room
Clinical applications and technical foundations of tran-
scranial Direct Current Stimulation (tDCS), a non-inva-
sive brain stimulation therapy, in psychiatric disorders
Chair:
Andre Brunoni, Brazil
Co-Chair: Emmanuel Poulet, France
S-35-001
TDCS in psychiatry: Mechanistic foundations and current
challenges
Frank Padberg, Germany
S-35-002
TDCS for neuromodulation of decision-making: Implica-
tions for the addictive brain
Shirley Fecteau, Canada
S. Fecteau
S-35-003
Clinical and biological evidence for using TDCS in schiz-
ophrenia
Jerome Brunelin, France
E. Poulet
S-35-004
TDCS in major depressive disorder: Results from rand-
omized clinical trials and follow-up studies
Andre Brunoni, Brazil
T23: N
euroimaging
: G
enetic
, F
unctional
, S
tructural
S-36
Symposium
11:00–12:30
Mitropoulos Hall
Brain imaging and treatment response
Chair:
Siegfried Kasper, Austria
Co-Chair: Lars Farde, Sweden
S-36-001
Multimodal imaging and treatment response in depression
Siegfried Kasper, Austria
S-36-002
Targets for deep brain stimulation in depression
Thomas Schlaepfer, Germany
S-36-003
D2-receptor occupancy and treatment reponse in schizo-
phrenia revisited
Lars Farde, Sweden
S-36-004
Imaging of the glutamatergic neuroreceptors, a new target?
Erich Seifritz, Switzerland
T16: G
enetics
S-37
Symposium
11:00–12:30
Skalkotas Hall
Immunogenetics: Exploring new territory in schizophrenia
Chair:
James Kennedy, Canada
Co-Chair: Jennie Pouget, Canada
S-37-001
Common variation does not support involvement of im-
mune loci in schizophrenia
Jennie Pouget, Canada
V. Goncalves, J. Kennedy, J. Knight
S-37-002
The schizophrenia and bipolar polygenic scores: Associa-
tion with clinical and serologic markers
Faith B. Dickerson, USA
S-37-003
An extreme form of structural variation in the human HLA
locus
Steven McCarroll, USA
S-37-004
The viral microbiome: The missing link in the pathogenesis
of schizophrenia
Robert Yolken, USA
F. B. Dickerson